EMEA-000813-PIP01-09-M01 - paediatric investigation plan

13 Grass Aqueous Extract

Key facts

• Active Substance:
  13 Grass Aqueous Extract
• Therapeutic area:
  Pneumology-allergology
• Decision number:
  P/0177/2024
• PIP number:
  EMEA-000813-PIP01-09-M01
• Pharmaceutical form(s):
  Suspension for injection
• Condition(s) / indication(s):
  Treatment of allergic rhinitis / rhino-conjunctivitis
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  06/05/2024

Decision

P/0177/2024: EMA decision of 6 May 2024 on the acceptance of a modification of an agreed paediatric investigation plan for 13 Grass Aqueous Extract (EMEA-000813-PIP01-09-M01)

Reference Number: EMA/105457/2024